Nova Anchora
a biotechnology company developing a corrective topical protein therapy for dystrophic epidermolysis bullosa (DEB)
Biotechnology
Amount raised
$23M
Round
—
Date raised
November 5, 2026
Founded
—
CompanyNova Anchora
IndustryBiotechnology
InvestorsViking Global Investors
Founders
- Jason BhardwajCo-founder and Chief Executive Officer
- Peter MarinkovichCo-founder and Chair
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Nova Anchora
a biotechnology company developing a corrective topical protein therapy for dystrophic epidermolysis bullosa (DEB)
- How much did Nova Anchora raise?
- Nova Anchora raised $23M on November 5, 2026. Investors include Viking Global Investors.
- Who founded Nova Anchora?
- Jason Bhardwaj and Peter Marinkovich co-founded Nova Anchora.